Oflokasin (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Oflokasin, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It treats a range of serious bacterial infections in adults, including community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, intra‑abdominal infections, and complicated urinary tract infections.

GNH USA supplies Oflokasin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in various organ systems.

Community‑acquired pneumonia: achieves clinical cure and microbiological eradication. Acute bacterial sinusitis: reduces symptoms and eliminates the causative pathogens. Skin and soft‑tissue infections: provides rapid bacterial clearance. Intra‑abdominal infections: effective against mixed aerobic and anaerobic organisms. Complicated urinary tract infections: resolves infection and prevents recurrence.

Moxifloxacin may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea or vomiting. - Diarrhea. - Headache. - Dizziness. - Elevated liver enzymes. - Rash or mild skin irritation.

Serious or Rare Side Effects: - Tendon rupture or tendinitis, especially in the Achilles tendon. - QT interval prolongation leading to cardiac arrhythmias. - Severe hypersensitivity reactions such as Stevens‑Johnson syndrome. - Clostridioides difficile‑associated colitis. - Peripheral neuropathy. - Hepatotoxicity with jaundice.

When using Oflokasin, clinicians should consider several safety measures.

Renal or hepatic impairment: adjust therapy based on clinical judgment. Concomitant QT‑prolonging drugs: monitor cardiac rhythm. History of tendon disorders: avoid use in patients with prior tendon injury. Pregnancy and lactation: weigh benefits against potential risks. Elderly patients: observe for increased susceptibility to adverse events. Store at ambient temperature: keep in original container, protect from light and moisture.

Moxifloxacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption. - Warfarin: may increase INR and bleeding risk. - Theophylline: can raise serum theophylline levels. - Cyclosporine: may increase cyclosporine concentrations. - Antidiabetic agents: potential for hypoglycemia.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of CNS stimulation. - Corticosteroids: heightened risk of tendon rupture. - Other fluoroquinolones: additive QT prolongation. - Rifampin: may reduce moxifloxacin plasma levels.